61 f f 3M Specialty Materials 3M Center St.
refid# Md7pY4OYqag64K3Z8avx58aL1 page
DRAFT m S .M - I& 7 Y Telomer Research Program 2003APR 2 ^ PM 2 : 0 7 LC/MS/MS Analysis of Articles and Products: Samples and Suggested Sampling Procedures Marilyn A.
refid# g2ZRJQNxMjw5V95ovJ8kYLjde5 pages
to COLUM BUS, OHIO OFFICE TW ELFTH FLOOR 21 E A ST STATE S T R E E T COLUM BUS, O HIO 43215*4221 614-221-2838 FAX: 614 -2 21 -2 0 07 Ro b er ta .
refid# Ra917ko5G5JVDDg35Lwqzj8Y72 pages
Krtfcsrtw E.
refid# V3e4KyDXoL3zjv9QL0bg32wON2 pages
AR226-1486 ENVIRONMENTAL AND HEALTH ASSESSMENT OF PERFLUOROOCTANE SULFONIC ACID AND ITS SALTS August 20, 2003 Prepared by 3M in consultation with Jack Moore, D.V.M., DABT, Hollyhouse, Inc.
refid# MG41y25p5VzG4YqQdjBgYpBoy638 pages
3M Strategic Toxicology Laboratory Study Title: Acute Inhalation Toxicokinetic Study of Perfluoroctanesulfonyl Fluoride (POSF) T-7098.4 Test Number (sample): , T-7098.4 (Perfluoroctanesulfonyl Fluoride (POSF) Laboratory Project Identification: ST64 In-Life Initiation Date: 5/1/2001 In-Life Completion Date: 5/14/2001 Research Client: 3M Specialty Materials Division 3M Center Building 236 Saint Paul, MN 55133-3220 Testing Laboratory: 3M Strategic Toxicology Laboratory 3M Center Building 270-SB-181 Saint Paul, MN 55133-3220 Study Director: Andrew M.
refid# ZBje3Zm2ZRG7z1ENyk7G5V6q818 pages
PFOS: A PILOT REPRODUCTION STUDY WITH THE NORTHERN BOBWHITE FINAL REPORT WILDLIFE INTERNATIONAL, LTD.
refid# zzNgMB3wz6eyLo9RB6mYjkd3B125 pages
ATTACHMENT TO LETTER OF 12/05/05 3M FLUOROCHEMICAL SUBMISSION BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE Click on Study Title to View Report Multiple Chemicals 1.
refid# 3eXEaV180vqmmNd8p0LzLKbbn1 page
COMMENTS OF 3M COMPANY TO THE EPA SCIENCE ADVISORY BOARD PFOA REVIEW PANEL Contact: Geary Olsen, D.V.M., PhD.
refid# DDVK2qJpJvXb5GJ9o4GgDzBQM10 pages
SRPT T-6295.8, T-6889.1, T-6316.4 DTI 5-A 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title; Inter-Species Comparison of Mechanisms Fluorochemicai Toxicity following Intraperitoneal dosing of perfluorooctanesulfonate (PFOS, T-6295) or ammonium perfluorooctanoate (APFO, T-6889) in Rats and Guinea Pigs and oral dosing of N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316) in Rats.
refid# EvKK0KQ9JZEwJ1vnR8Yqxm5VL44 pages
y L\ ^ * DuPont Haskell VFn. f.
refid# ErKvV2XeGQzoRyeakLnQqbLx1 page
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 MG 8 2000 Mr.
refid# n9KyZm1oGZMrpOK5wxpqgo7Om2 pages
4r* 226-2047 Roger J Zipfel 07/27/2001 01:30 PM To: John E Crum/SE/DuPont@DuPont cc: Ta-W ei Fu/CL/DuPont@DuPont Subject Re: C-8 sampling Q John, this is very perplexing information.
refid# 6RdvmkxvBGp0RbV7dxJyJ3xQ32 pages
$ rr 3M Katherine E.
refid# nkmgk1gJ5bdbeN5NZrEb3Zp4w1 page
P-1 AR R 9 .6 - 562*1.
refid# dEdm0NVoQexj9Enb9na4zOGB132 pages